Newly released Survival Data (from ASCO) with Oncosil devise and SOC demonstrates:-
(1) 64% of implanted patients were alive after 12 months.
(2) 50% of implanted patients (21/42) were alive after 16 months.
(3) Average overall survival of 16 months.
Compared to SOC (chemo only) of 9-11 months.
IMO this demonstrates efficacy and should be approved by the regulators.
Newly released Survival Data (from ASCO) with Oncosil devise and...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.02 |
Change
0.020(2.00%) |
Mkt cap ! $14.50M | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.04 | 99.5¢ | $44.12K | 44.03K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 968 | $1.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 6234 | 1 |
View Market Depth
| Last trade - 15.28pm 25/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |